AI-generated summary
This prospective study of 21 patients with 54 keloids assessed dual-wavelength laser therapy (585 nm pulsed dye and 1,064 nm Nd:YAG) using laser speckle contrast imaging and the Vancouver Scar Scale. The authors report that blood perfusion and Vancouver Scar Scale scores decreased after treatment, with perfusion change correlating with score change. The authors suggest the imaging method may be a promising objective measure.
- Participants
- 21
- Who or what was studied
- 21 patients with 54 keloids
- Wavelengths
- 585 nm
- Limits stated in the abstract
- The abstract does not describe a control group, and the sample is small, so the findings cannot establish treatment effectiveness.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 064 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.